General
Preferred name
cymarin
Synonyms
CYMARINE ()
K-strophanthin-.alpha. ()
K-strophanthin-alpha ()
NSC-7522 ()
P&D ID
PD071803
CAS
508-77-0
Tags
available
drug
Drug Status
approved
experimental
Drug indication
Cardiovascular disease
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION Cymarin, a cardiac glycoside, potently inhibits the Palytoxin (PTX)-induced K+ release (IC50=0.42 ¦ÌM). Cymarin reveals an antitumor activity against breast cancer and pancreatic cancer. Cymarin exhibits antifeedant and growth inhibitory effects as crop protectant[1][2][3][4].
Cell lines
1
Organisms
1
Compound Sets
5
ChEMBL Drugs
DrugBank
DrugCentral
DrugCentral Approved Drugs
MedChem Express Bioactive Compound Library
External IDs
28
Properties
(calculated by RDKit )
Molecular Weight
548.3
Hydrogen Bond Acceptors
9
Hydrogen Bond Donors
3
Rotatable Bonds
5
Ring Count
6
Aromatic Ring Count
0
cLogP
2.43
TPSA
131.75
Fraction CSP3
0.87
Chiral centers
12.0
Largest ring
6.0
QED
0.27
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Pathway
Anti-infection
Membrane Transporter/Ion Channel
Target
Parasite
Potassium Channel
Source data